Health

Results: 253-264 of 4405

Incyte Late-Breaking Tafasitamab (Monjuvi®) Data at ASH 2024 Demonstrate Significantly Improved Progression-Free Survival in Patients with Relapsed or Refractory Follicular Lymphoma

Ultrastructural representation of the BK polyomavirus capsid, featuring 72 pentamers that form its distinct icosahedral symmetry. (Graphic: Business Wire)

Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

PR Newswire associated0

Endo Launches Doxycycline for Injection, USP

NHS set to benefit from £23 million following CMA pharma probe

Health Secretary asks NHS to prioritise patient safety for winter

Maximilien Levesque, CEO and Cofounder of AQEMIA (left) and Emmanuelle Martiano Rolland, COO and Cofounder of AQEMIA (Photo: Business Wire)

AQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK

Wyss Center for Bio and Neuroengineering Announces Venture with dEEGtal Insight: An Innovative Tool for Early Epilepsy Detection

Sirius Therapeutics Announces Promising Phase I Clinical Data from Its Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders

BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets

Monica Lewinsky Visits Agnivesh Agarwal’s Primeks Medical in Istanbul

PR Newswire associated1

Seoul National University Bundang Hospital Establishes the first "International PSP Research and Treatment Center" in Korea